At present, the therapeutic effect of pancreatic cancer is limited; we hope that the target of KIF2C can provide new ideas for its treatment, so that patients who cannot receive timely surgical treatment can obtain a better prognosis. This evidence concerns the gene KIF2C and pancreatic neoplasm.